Apyx Medical Corporation (APYX)
APYX Stock Price Chart
Explore Apyx Medical Corporation interactive price chart. Choose custom timeframes to analyze APYX price movements and trends.
APYX Company Profile
Discover essential business fundamentals and corporate details for Apyx Medical Corporation (APYX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Specialties
IPO Date
2 Jan 2019
Employees
205.00
Website
https://apyxmedical.comCEO
Charles D. Goodwin
Description
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
APYX Financial Timeline
Browse a chronological timeline of Apyx Medical Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$0.06, while revenue estimate is $13.18m.
Earnings released on 7 May 2026
EPS came in at -$0.05 surpassing the estimated -$0.11 by +54.55%, while revenue for the quarter reached $12.49m , beating expectations by +18.67%.
Earnings released on 10 Mar 2026
EPS came in at -$0.03 surpassing the estimated -$0.06 by +50.00%, while revenue for the quarter reached $19.16m , beating expectations by +3.37%.
Earnings released on 6 Nov 2025
EPS came in at -$0.05 surpassing the estimated -$0.06 by +16.67%, while revenue for the quarter reached $12.88m , missing expectations by -28.94%.
Earnings released on 7 Aug 2025
EPS came in at -$0.09 surpassing the estimated -$0.09 by +3.57%, while revenue for the quarter reached $11.37m , missing expectations by -2.79%.
Earnings released on 8 May 2025
EPS came in at -$0.10 surpassing the estimated -$0.12 by +16.67%, while revenue for the quarter reached $9.43m , beating expectations by +1.04%.
Earnings released on 13 Mar 2025
EPS came in at -$0.12 surpassing the estimated -$0.13 by +7.69%, while revenue for the quarter reached $14.22m , beating expectations by +44.02%.
Earnings released on 8 Nov 2024
EPS came in at -$0.14 surpassing the estimated -$0.15 by +6.67%, while revenue for the quarter reached $11.49m , missing expectations by -11.75%.
Earnings released on 8 Aug 2024
EPS came in at -$0.19 falling short of the estimated -$0.18 by -5.56%, while revenue for the quarter reached $12.15m , beating expectations by +3.40%.
Earnings released on 9 May 2024
EPS came in at -$0.22 falling short of the estimated -$0.18 by -22.22%, while revenue for the quarter reached $14.54m , beating expectations by +52.56%.
Earnings released on 21 Mar 2024
EPS came in at -$0.19 falling short of the estimated -$0.13 by -46.15%, while revenue for the quarter reached $14.66m , missing expectations by -1.27%.
Earnings released on 9 Nov 2023
EPS came in at -$0.13 falling short of the estimated -$0.10 by -30.00%, while revenue for the quarter reached $15.97m , beating expectations by +2.53%.
Earnings released on 10 Aug 2023
EPS came in at -$0.11 surpassing the estimated -$0.12 by +8.33%, while revenue for the quarter reached $13.57m , missing expectations by -5.24%.
Earnings released on 11 May 2023
EPS came in at -$0.10 falling short of the estimated -$0.06 by -66.67%, while revenue for the quarter reached $12.14m , beating expectations by +11.70%.
Earnings released on 16 Mar 2023
EPS came in at -$0.17 falling short of the estimated $0.14 by -221.43%, while revenue for the quarter reached $12.61m , missing expectations by -2.54%.
Earnings released on 10 Nov 2022
EPS came in at -$0.17 falling short of the estimated -$0.12 by -41.67%, while revenue for the quarter reached $9.11m , missing expectations by -24.11%.
Earnings released on 11 Aug 2022
EPS came in at -$0.16 surpassing the estimated -$0.20 by +20.00%, while revenue for the quarter reached $10.29m , missing expectations by -2.51%.
Earnings released on 12 May 2022
EPS came in at -$0.17 falling short of the estimated -$0.13 by -30.77%, while revenue for the quarter reached $12.49m , beating expectations by +12.33%.
Earnings released on 17 Mar 2022
EPS came in at -$0.06 surpassing the estimated -$0.13 by +53.85%, while revenue for the quarter reached $16.82m , beating expectations by +15.02%.
Earnings released on 11 Nov 2021
EPS came in at -$0.12 surpassing the estimated -$0.15 by +20.00%, while revenue for the quarter reached $11.83m , missing expectations by -16.67%.
Earnings released on 12 Aug 2021
EPS came in at -$0.12 surpassing the estimated -$0.14 by +14.29%, while revenue for the quarter reached $11.22m , meeting expectations.
APYX Stock Performance
Access detailed APYX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
